Matches in Nanopublications for { ?s ?p "[Switching from the current standard of care vemurafenib therapy to the double BRAF/MEK inhibition in BRAF mutant melanoma patients results in rapid disappearance of established proliferative skin disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Switching from the current standard of care vemurafenib therapy to the double BRAF/MEK inhibition in BRAF mutant melanoma patients results in rapid disappearance of established proliferative skin disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1216528.RARKrtqgjq4PgmaansuUidFlzNQ7xSEjYuoZGbZHPqZ1E130_assertion description "[Switching from the current standard of care vemurafenib therapy to the double BRAF/MEK inhibition in BRAF mutant melanoma patients results in rapid disappearance of established proliferative skin disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216528.RARKrtqgjq4PgmaansuUidFlzNQ7xSEjYuoZGbZHPqZ1E130_provenance.